Key result
CASS registry yields 26 technology assessments on CABG, risk factors, and diagnostic tools.
Why the study?
The Coronary Artery Surgery Study (CASS) registry data have been used to evaluate therapeutic capabilities of coronary artery bypass graft surgery and other cardiovascular technologies, but a comprehensive assessment of these technological evaluations was needed.
The CASS registry has provided valuable data for technology assessment, including the evaluation of CABG, diagnostic technologies, quality of life, and costs.
Highlights legacy registry utility for technology assessment; leaves open need for updated validation in contemporary practice.
The majority of the 26 technology assessment articles from the Coronary Artery Surgery Study (CASS) follow the original purpose of the registry and evaluate the therapeutic capabilities of coronary artery bypass graft surgery. However, these registry data have also been used to identify risk factors for cardiovascular disease, to test diagnostic technologies, and to evaluate technological processes. Consideration of quality of life issues and the availability of cost data provide valuable additions to the continued use of the CASS for technology assessment.
No takes yet. Share an insight, caveat, or question.
Burdick et al. (1991) conducted a review in Cardiovascular disease. Coronary artery bypass graft surgery was evaluated. The Coronary Artery Surgery Study (CASS) registry data provided the basis for 26 technology assessment articles evaluating coronary artery bypass graft surgery, risk factors, and diagnostic technologies.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: